Company Description
Cancer patients will hopefully get a helpful shot in the arm thanks to Abraxis BioScience. Having spun off its generic injectable drug business, the...
Key Abraxis BioScience Financials
| Company Type | Public - NASDAQ (GS): ABII Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $333.7 |
| 2006 Employees | 1,864 |
More Abraxis BioScience Financials (11 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Abraxis BioScience's competition across multiple industries
Top Abraxis BioScience Competitors
Sponsored Links
The Business Directory
Abraxis BioScience Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Patrick Soon-Shiong | Network | E-mail |
| EVP Corporate Development | Bruce J. Wendel | Network | E-mail |
| VP, Marketing | Deena Reyes | Network | E-mail |
More Abraxis BioScience Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Abraxis BioScience News
- BioWorld Today September 5, 2008 [BioWorld Today] (05 Sep 2008 00:01:00 EDT)
- Business staffing plans for Thursday, Sept. 4, 2008 [Canadian Press DataFile] (04 Sep 2008 00:01:00 EDT)
- ProMetic signs licensing, investment agreements with Abraxis BioScience [Canadian Press DataFile] (04 Sep 2008 00:01:00 EDT)
Sponsored Opportunity
